Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1999 | 03-1999 | 12-1998 | 09-1998 | 06-1998 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,100 | 12,920 | 4,440 | 7,700 | 10,990 |
| Marketable Securities | 11,140 | 9,500 | 22,330 | 19,090 | 21,420 |
| Receivables | 410 | 1,170 | 600 | 990 | 400 |
| Inventories | 340 | 340 | 370 | 440 | 460 |
| Other current assets | 80 | 150 | 390 | 250 | 310 |
| TOTAL | $23,070 | $24,080 | $28,130 | $28,470 | $33,580 |
| Non-Current Assets | |||||
| PPE Net | 13,920 | 13,920 | 13,840 | 13,660 | 13,520 |
| Other Non-Current Assets | 360 | 300 | 300 | 300 | 300 |
| TOTAL | $14,280 | $14,220 | $14,140 | $13,960 | $13,820 |
| Total Assets | $28,420 | $29,560 | $33,740 | $34,110 | $39,320 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 310 | 290 | 700 | 420 | 400 |
| Accrued Expenses | 560 | 690 | 540 | 720 | 480 |
| TOTAL | $940 | $1,040 | $1,290 | $1,190 | $930 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $940 | $1,040 | $1,290 | $1,190 | $930 |
| Shareholders' Equity | |||||
| Common Shares | 60 | 60 | 60 | 60 | 60 |
| Retained earnings | -18,140 | -15,800 | -15,010 | -12,400 | -10,380 |
| Other shareholders' equity | 1,280 | -10 | 3,130 | 990 | 4,440 |
| TOTAL | $27,480 | $28,520 | $32,450 | $32,920 | $38,390 |
| Total Liabilities And Equity | $28,420 | $29,560 | $33,740 | $34,110 | $39,320 |